Harbin Medisan Pharmaceutical Co., Ltd. (002900-SZ) Stock Split, History Data
Working capital analysis
In terms of working capital, Harbin Medisan Pharmaceutical Co., Ltd. maintains a healthy position.
The total current assets of the company are valued at $1436438737.
This represents a growth rate of -11.531% compared to the previous year.
Breaking down the current assets, the cash and investments are worth $991162246, exhibiting a growth rate of -17.585% year-on-year.
The receivables, another significant portion of the current assets, are valued at $150572029.
The year-on-year growth rate for receivables is -8.217%.
The inventory, which forms a critical part of the assets, is valued at $208787058.
This represents a healthy year-on-year growth of 29.552%
On the liabilities side, the company's current liabilities total $845034070.
This reflects a growth rate of 41.373% over the previous year, indicating the company's financial obligations are well under control.
2023
2022
2021
2020
2019
2018
Cash and investments
991.16
1202.65
529.83
661.45
471.49
451.69
Receavebles
150.57
164.05
149.63
204.68
256.11
249.82
Inventory
208.79
161.16
156.55
186.51
214.34
183.94
Other
28.16
4.55
9.50
26.73
46.93
654.85
Total Current Assets
1436.44
1623.66
1427.19
1440.16
1685.59
1645.21
Acc Payable
182.13
120.84
105.16
90.01
96.37
76.81
Short Term Debt
480.22
233.80
274.80
269.78
180.00
58.00
Other Current Liab
7.92
188.31
2.53
2.07
96.69
293.32
Current Liabilities
845.03
597.73
536.61
588.84
723.30
447.19
Capital Structure
When examining the capital structure of Harbin Medisan Pharmaceutical Co., Ltd., it is clear that the company manages a robust portfolio.
These earnings represent the profits that Harbin Medisan Pharmaceutical Co., Ltd. has chosen to reinvest in the business rather than distribute as dividends.
